Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 389 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary |
| |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham |
| |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company GENIXUS Corp. | Activity: Production and Manufacturing | Company Description GENIXUS provides innovative manufacturing and novel delivery systems for acute and critical care medicines. GENIXUS produces pharmaceutical sterile injectables, incorporating technology for ease of tracking, utilizing novel syringes that avoid breakage and promote longer shelf life. | Location Kannapolis |
| |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Glycan Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Glycan Therapeutics offers solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs), specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics offers research reagents, analytical and microarray services, and a drug development program. | Location Raleigh |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company Green Oil Company LLC | Activity: Production and Manufacturing | Company Description Green Oil processes waste vegetable oil from restaurants to produce fatty acid methyl/ethyl esters for biodiesel and other compounds and additives, plant biomass to produce cannabinoids for health products, biochar and compost for biofiltration, soil amendments and carbon sequestration. | Location Efland |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company Guerbet LLC | Activity: Production and Manufacturing | Company Description Guerbet manufactures contrast media used in diagnostic imaging tests. | Location Raleigh |
| |
Company Gusmer Enterprises Inc. | Activity: Production and Manufacturing | Company Description Gusmer Enterprises manufactures liquid filtration media and devices used in the beverage, food, and pharmaceutical industries. This GMP manufacturing facility produces filtering devices for liquids including COVID-19 treatments. | Location Newton |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hedros Biotechnology | Activity: Research and Development | Company Description Hedros Biotechnology has developed a software platform to create custom bacteriophage cocktails, with the goal to eradicate acute hepatopancreatic necrosis disease (AHPND) in shrimp. | Location Raleigh |
| |
Company HeiQ ChemTex Inc. | Activity: Production and Manufacturing | Company Description HeiQ ChemTex develops and manufactures specialty chemicals for the carpet, textiles, paper, coated fabrics, oil field recovery and specialty surfactants industries. Its product Bac-Shield contains a natural microbial extracted from snow crab shells. | Location Concord |
| |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh |
| |
Company Hemo Bioscience Inc. | Activity: Production and Manufacturing | Company Description Hemo Bioscience is an FDA-registered, ISO 13485-accredited manufacturer of blood-typing reagents and diagnostics for the blood-banking industry. | Location Durham |
| |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh |
| |
Company HOMS LLC | Activity: Production and Manufacturing | Company Description HOMS develops, manufactures and markets natural products for pest management. | Location Pittsboro |
| |
Company Hoofprint Biome | Activity: Research and Development | Company Description Hoofprint Biome engineers probiotics to eliminate methane from livestock while improving production performance. | Location Raleigh |
| |
Company HTX Technologies LLC | Activity: Production and Manufacturing | Company Description HTX Technologies develops tissue imaging and molecular imaging technologies, with a primary focus on sample preparation and mass spectrometry imaging. | Location Chapel Hill |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Ideal Health Biotechnology LLC | Activity: Research and Development | Company Description Ideal Health Biotechnology researches and develops dietary supplements made from plant-based compounds, including products derived from grape seed extract and algae for digestion, eye disease and diabetes. | Location Kannapolis |
| |
Company Iluma Alliance | Activity: Research and Development | Company Description Iluma Alliance develops, manufactures and markets nutritional and health ingredients for animals, as well as nutritional ingredients for humans. This location is the innovation labs and conducts research on feed additives for animal nutrition and health. | Location Durham |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company ImmunoReagents Inc. | Activity: Production and Manufacturing | Company Description ImmunoReagents manufactures primary and secondary polyclonal antibodies used in research and in vitro diagnostics for the pharmaceutical and veterinary markets. | Location Raleigh |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |
| |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Indigo Agriculture | Activity: Research and Development | Company Description Indigo Agriculture utilizes plant microbes to improve crop health and productivity, with a portfolio focused on cotton, wheat, corn, soybeans and rice. | Location Research Triangle Park |
| |
Company IngateyGen LLC | Activity: Research and Development | Company Description IngateyGen is an early stage Ag Biotech company using CRISPR genome editing technology to develop an allergen reduced peanut, a peanut with modified oil profile and an ultra high protein peanut for improved safety and nutritional value to consumers. | Location Research Triangle Park |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Innatrix Inc. | Activity: Research and Development | Company Description Innatrix is developing eco-friendly alternative means of crop protection, utilizing a patented peptide & RNAi delivery technology platform. | Location Research Triangle Park |
| |
Company Innovative Neurophysiology Inc. | Activity: Research and Development | Company Description Innovative Neurophysiology designs and develops advanced tools, equipment and methodology for neuroscience research. | Location Durham |
| |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham |
| |
Company Integrated Precision Metabolomics | Activity: Research and Development | Company Description Integrated Precision Metabolomics is developing a new type of mass spectrometer instrumentation and related software that will enable easier metabolomics analysis by end users. | Location Chapel Hill |
| |
Company Interventional AnalgesiX Inc. | Activity: Research and Development | Company Description Interventional AnalgesiX is developing non-addictive analgesics for chronic pain. | Location Durham |
| |
Company Invaio Sciences Inc. | Activity: Research and Development | Company Description Invaio Sciences is developing sustainable methods for managing plant pests and pathogens. As a multi-platform technology company, Invaio utilizes natural systems to solve pressing agriculture, nutrition, & environmental challenges. | Location Durham |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Isolere Bio Inc. | Activity: Research and Development | Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. | Location Durham |
| |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville |
| |
Company JABB of the Carolinas Inc. | Activity: Production and Manufacturing | Company Description JABB develops and manufactures fungal soil additives and biopesticide products. JABB also offers contract manufacturing for specific fungal products. | Location Pine Level |